Your browser doesn't support javascript.
loading
Are different methotrexate regimens as first line therapy for low risk gestational trophoblastic neoplasia more cost effective than the dactinomycin regimen used in GOG 0174?
Miller, Caela R; Chappell, Nicole P; Sledge, Caitlin; Leath, Charles A; Phippen, Neil T; Havrilesky, Laura J; Barnett, Jason C.
Afiliação
  • Miller CR; San Antonio Military Medical Center, Ft Sam Houston, TX, United States. Electronic address: caela.r.miller.mil@mail.mil.
  • Chappell NP; San Antonio Military Medical Center, Ft Sam Houston, TX, United States.
  • Sledge C; San Antonio Military Medical Center, Ft Sam Houston, TX, United States.
  • Leath CA; University of Alabama at Birmingham, Birmingham, AL, United States.
  • Phippen NT; Walter Reed National Military Medical Center, Bethesda, MD, United States.
  • Havrilesky LJ; Duke University Medical Center, Durham, NC, United States.
  • Barnett JC; San Antonio Military Medical Center, Ft Sam Houston, TX, United States.
Gynecol Oncol ; 144(1): 125-129, 2017 Jan.
Article em En | MEDLINE | ID: mdl-27816248

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Metotrexato / Dactinomicina / Doença Trofoblástica Gestacional / Antibióticos Antineoplásicos / Antimetabólitos Antineoplásicos Tipo de estudo: Clinical_trials / Etiology_studies / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Pregnancy Idioma: En Revista: Gynecol Oncol Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Metotrexato / Dactinomicina / Doença Trofoblástica Gestacional / Antibióticos Antineoplásicos / Antimetabólitos Antineoplásicos Tipo de estudo: Clinical_trials / Etiology_studies / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Pregnancy Idioma: En Revista: Gynecol Oncol Ano de publicação: 2017 Tipo de documento: Article